About Us

Bionic Power’s purpose is to design and develop lower-body smart orthoses that improve quality of life by enhancing personal mobility and walking abilities.

Bionic Power Inc. is a Canadian, privately held company that has developed and holds IP rights on wearable technology. This technology addresses the rapidly growing market for mobility assistance in patients with knee pathologies and both military and consumer use for endurance enhancement. Our Agilik medical device targets pediatric patients with crouch gait due to various pathologies such as cerebral palsy, spina bifida, muscular dystrophy and other knee-extension-deficiency disorders whose strength and endurance often deteriorate as they get older. Its proprietary technology has been developed through partnerships with and research grants from the Canadian, US and Israeli governments.
Stand Taller, Walk Stronger™

The Management

Gualtiero Guadagni – CEO (PhD)

Hired in Q3 2021
Former president of Dialco Medical Inc.
23 years in medical devices (clinical development, commercialization, regulatory and manufacturing).

Clive Mullins – CTO

31 years in product development
14 years of gait analysis and exoskeleton design and development experience.
Past experience with Delta Q, Ciena Networks, Nortel

George Lawton – CFO (CPA, CA)

Extensive public and private company CFO experience.

The Board

Yad Garcha – Co-Founder and Chairman of the Board

Mr. Garcha’s venture-capital background spans nearly two decades in the biotech, medical device, and pharmaceutical sectors. A former senior vice-president at GrowthWorks Capital, Mr. Garcha also worked at the Business Development Bank of Canada. As a VC, Mr. Garcha backed Angiotech, Anormed (sold to Genzyme) and Creo Products (sold to Kodak). Mr. Garcha earned a Bachelor of Science in Microbiology from the University of British Columbia, and an MBA from the University of Western Ontario.

Gualtiero Guadagni – Chief Executive Officer

Dr. Guadagni brings almost 25 years of extensive experience in regulatory development, commercialization, and R&D of medical devices. Prior to joining the company, he was President of Dialco Medical Inc. Dr. Guadagni received his Ph.D. in bioengineering and a master’s degree in mechanical engineering from Politecnico di Milano University in Italy.

Marc de La Bruyère – Director

Mr. de La Bruyère is the Principal of Maclab Development Group, a real estate development and investment firm. Mr. de La Bruyère began his professional career as an associate with management consultancy McKinsey and Company and recently served as the Chairman of Viewtrak Technologies, a livestock information technology company.

Darrell Elliott – Director

Darrell Elliott is a career Investment Professional with over 45 years of investing experience and has served on over 100 Boards. He was an early pioneer in the Canadian venture capital industry, including Nimbus Strategies. As Chairman and CEO, Mr. Elliott raised the first publicly traded biotechnology SPAC on Wall Street (NYSE) in 2007. He has extensive operating experience at the C-suite level, including completing M&A of several public companies. He grew a publicly traded conglomerate from 6 to 42 companies over 18 months by acquisition and reorganization. His military experience is comprised of eleven part-time years as an army commissioned operator in a special operations force regiment active in Africa.

FABRIZIO BROCCHIERI – DIRECTOR

Fabrizio Brocchieri is an experienced financial advisor and executive with over 25 years of practice in execution and financing of M&A transactions. He has also been chief financial officer and board member of a renewable energy company from the start-up phase until the financial sponsor exit, through the international expansion and strategic re-positioning of the sustainable E-mobility business. Fabrizio spent most of his professional career working for Deutsche Bank Corporate and Investment Banking, Intesa Sanpaolo International Banking Division and he is currently managing director of Capital Insight Partners, an independent financial advisory boutique. Fabrizio graduated from the Università Cattolica del Sacro Cuore, and lives in Milan with his wife and four children.

Clinical Advisory Board

Dr. Paulo RP Selber
MD, FSBOT, FRACS

Dr. Selber is an orthopedic surgeon who has been involved in the treatment of gait and movement disorders in pediatric, adolescent, and adult patients for more than 25 years. He specializes in conditions such as cerebral palsy, spina bifida and several neuromuscular conditions. Early in 2022, Dr. Selber joined HSS where he collaborates with the Dr. Leon Root Motion Analysis Laboratory and continues to care for ambulatory and non-ambulatory children and adults with cerebral palsy.



Dr. David M. Scher – MD

Dr. Scher is a Professor of Clinical Orthopaedic Surgery at Weill Cornell Medical College and an Attending Orthopaedic Surgeon in the Division of Pediatric Orthopaedic Surgery at Hospital for Special Surgery in New York City, where he is co-medical director of the Leon Root Motion Analysis Lab.

Dr. Christine Alvarez – MSc, FRCPC, BSc, MD

Dr. Alvarez is a Clinical Professor in the Division of Paediatric Orthopaedic Surgery at the British Columbia Children’s Hospital, University of British Columbia. She has been a faculty member for 22 years and a clinical member/ co-director of the Shriner’s Gait Lab since 2000. Her clinical expertise includes paediatric foot and ankle conditions, Hereditary Multiple Exostosis, spinal cord clinic including congenital and acquired conditions, cerebral palsy, arthrogryposis and gait analysis. She founded and has maintained specialty clinics for HME and complex foot deformities including clubfoot. Dr. Alvarez has been part of impactful committees at the local, national and international level: including the teaching faculty, Advisory Committee for the International Society for Arhrogryposis,  Steering Committee for Canadian Botulinum Toxin conference, Orthopaedic Redesign Committee, Trauma Committee and Computer Services Transformation.

Dr. Thomas C. Bulea – PhD

Dr. Bulea received his Ph.D. in biomedical engineering from Case Western Reserve University and is a Tenure Track Investigator in the Rehabilitation Medicine Department at the National Institutes of Health in Bethesda, MD. Dr. Bulea’s research focuses on integration of neural interfacing with rehabilitation robotics to develop new therapeutic tools and interventions for treatment of movement disorders and paralysis. Dr. Bulea is the principal investigator on the NIH trial of the Agilik and a co-inventor of the Agilik system.

Dr. Thomas C. Bulea is an employee of the NIH Clinical Center which is part of the National Institutes of Health, an Agency under the US Department of Health and Human Services. Any reference to NIH or to Dr. Bulea should not be viewed as an endorsement of Bionic Power, Inc., its products or services.

Clinical Advisory Board

Dr. Paulo RP Selber
MD, FSBOT, FRACS

Dr. Selber is an orthopedic surgeon who has been involved in the treatment of gait and movement disorders in pediatric, adolescent, and adult patients for more than 25 years. He specializes in conditions such as cerebral palsy, spina bifida and several neuromuscular conditions. Early in 2022, Dr. Selber joined HSS where he collaborates with the Dr. Leon Root Motion Analysis Laboratory and continues to care for ambulatory and non-ambulatory children and adults with cerebral palsy.



Dr. David M. Scher – MD

Dr. Scher is a Professor of Clinical Orthopaedic Surgery at Weill Cornell Medical College and an Attending Orthopaedic Surgeon in the Division of Pediatric Orthopaedic Surgery at Hospital for Special Surgery in New York City, where he is co-medical director of the Leon Root Motion Analysis Lab.

Dr. Thomas C. Bulea – PhD

Dr. Bulea received his Ph.D. in biomedical engineering from Case Western Reserve University and is a Tenure Track Investigator in the Rehabilitation Medicine Department at the National Institutes of Health in Bethesda, MD. Dr. Bulea’s research focuses on integration of neural interfacing with rehabilitation robotics to develop new therapeutic tools and interventions for treatment of movement disorders and paralysis. Dr. Bulea is the principal investigator on the NIH trial of the Agilik and a co-inventor of the Agilik system.

Dr. Thomas C. Bulea is an employee of the NIH Clinical Center which is part of the National Institutes of Health, an Agency under the US Department of Health and Human Services. Any reference to NIH or to Dr. Bulea should not be viewed as an endorsement of Bionic Power, Inc., its products or services.

Dr. Christine Alvarez – MSc, FRCPC, BSc, MD

Dr. Alvarez is a Clinical Professor in the Division of Paediatric Orthopaedic Surgery at the British Columbia Children’s Hospital, University of British Columbia. She has been a faculty member for 22 years and a clinical member/ co-director of the Shriner’s Gait Lab since 2000. Her clinical expertise includes paediatric foot and ankle conditions, Hereditary Multiple Exostosis, spinal cord clinic including congenital and acquired conditions, cerebral palsy, arthrogryposis and gait analysis. She founded and has maintained specialty clinics for HME and complex foot deformities including clubfoot. Dr. Alvarez has been part of impactful committees at the local, national and international level: including the teaching faculty, Advisory Committee for the International Society for Arhrogryposis,  Steering Committee for Canadian Botulinum Toxin conference, Orthopaedic Redesign Committee, Trauma Committee and Computer Services Transformation.